Table 1.
Antagonist | Effect on spontaneous contractile activity† |
Effect on stimulated contractile activity† |
||||
---|---|---|---|---|---|---|
Control response to NaHS |
Response to NaHS with antagonist |
p | Control response to NaHS |
Response to NaHS with antagonist |
p | |
NANC conditions |
−47±14 | −74±14 * | <0.02 | - | - | - |
TTX | −34±12 | −81±8 * | <0.01 | −62±7 | −74±3 * | <0.05 |
Capsaicin | −34±12 | −66±12 * | <0.01 | −62±7 | −69±8 | 0.09 |
L-NNA | −53±10 | −77±10 * | <0.03 | −69±9 | −80±5 * | <0.01 |
Glibenclamide | −53±10 | −68±6 | 0.23 | −69±9 | −42±7 * | <0.01 |
Percent change from baseline contractile activity; ; n=8 rats
Differs from control response under same condition (spontaneous or stimulated contractile activity; ANOVA)
NANC: non-adrenergic, non-cholinergic
TTX: tetrodotoxin
L-NNA: L-NG-nitro arginine